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Pt(IV), Pd(II), and Rh(III) complexes induced oxidative stress and cytotoxicity in the
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Abstract: The use of transition metal complexes as appropriate analogues to cisplatin and similar anticancer drugs nowadays is of
utmost importance. The inertness of Pt(IV), Pd(II), and Rh(III) complexes and the choosing of convenient ligands could offer a possible
advantage in comparison to Pt(II) complexes. These advantages could be attributed to the better anticancer activity and fewer possible
side effects. In this paper, we have chosen three complexes of different transition metal ions, [(TLtBu)PdIICl]ClO4, [RhIII(LH2tBu)Cl3],
and [PtIV(LH2tBu)Cl3]Cl (where TLtBu is 2,6-bis[(1,3-di-tert-butylimidazolin-2-imino)methyl]pyridine and LH2tBu is 2,6-bis(5-tert-butyl1H-pyrazol-3-yl)pyridine), for biological tests. All three complexes exerted strong prooxidative and cytotoxic effects on the human
colorectal colon cancer HCT-116 cell line. The Pd(II) complex showed the most significant effect, while the Rh(III) complex showed
the least effect.
Key words: Anticancer activity, colon cancer, cytotoxicity, oxidative stress, palladium, platinum, rhodium

1. Introduction
Cancer is the second leading cause of death after
cardiovascular diseases, and finding the appropriate
therapy is of key medical and scientific interest, with
a potentially substantial economic impact. There are
about 200 different types of cancer of various incidences;
some are very common while others are rare (Penny and
Wallace, 2015). All types of cancer display a characteristic
uncontrolled cell division followed by the ability of
these cells to invade healthy tissues. The development of
cancer involves a series of complex mechanisms related
to the individual’s genetic characteristics and exposure
to certain risk factors. Understanding of the targets and
mechanisms of action of potential therapeutics in cancer
cells is essential for drug design and clinical applications
(Bergamo and Sava, 2015; Penny and Wallace, 2015).
Cisplatin was the first used metal-based drug in the
world. Although more than 40 years have passed since the
discovery of cisplatin’s antitumor properties, the platinum
drugs are the only metal-based drugs used in clinical
practice for the treatment of cancer. The advantages
and drawbacks of the widely used platinum-based
anticancer drug cisplatin prompted a search for analogous
transition metal complexes. One of the major goals of
* Correspondence: zivanovicm@kg.ac.rs

modern bioinorganic and medicinal chemistry research
is the development of novel metal-based drugs with
pharmaceutical activity different from that of platinumbased therapeutics (Lippert, 1999; Alessio, 2011; Bergamo
and Sava, 2015).
Initially it was assumed that the palladium(II) complexes
do not possess antitumor properties and, compared to
cisplatin, the corresponding cispalladium complex, cis[Pd(NH3)2Cl2], does not show antitumor activity. Since the
coordination chemistry of Pd(II) and Pt(II) compounds
is very similar, the Pd(II) complexes were very often used
as model molecules since they react about 104–105 times
faster than their Pt(II) analogues, whereas the structural
and equilibrium behaviors of the solutions are very similar
(Bugarčić et al., 2015). However, the introduction of some
spectator ligands in the coordination sphere of Pd(II) can
result in complexes with significant antitumor properties
(Abu-Surrah and Kettunen, 2006; Gao et al., 2008, 2009).
The main strategy in the designing of new metal-based
drugs is to create drugs that will be sufficiently reactive to
bind to the biological target, but not so reactive that they
will be deactivated by other biomolecules different from
the target; this can be achieved as a prodrug. A prodrug
is a compound that can undergo a transformation in vivo
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to release an active substance that could act as a drug in
situ. The Pt(IV) complexes are the most famous group
of prodrugs that can be used to overcome some of the
problems associated with cisplatin and its analogues.
The high kinetic inertness of platinum(IV) complexes
relative to their platinum(II) analogues introduces drug
stability and the two extra ligands on the octahedral
metal center offer many possibilities for modification of
pharmacokinetic parameters (Ronconi and Sadler, 2007;
Barry and Sadler, 2013).
Today’s research in the field of metal-based drugs is
also directed towards metal complexes from the 9th group
of the periodic table, iridium, osmium, and rhodium
complexes (Petrovic et al., 2008; Bogojeski et al., 2011;
Yoshinari et al., 2012). The main feature of these complexes
is inertness. However, the reactivity and biological activity
of these complexes can be improved by a suitable choice of
spectator ligands.
Recently we showed that the choosing of appropriate
ligands could provide palladium(II) complexes that are
extremely cytotoxic to cancer cells (Petrovic et al., 2015).
Under standard laboratory conditions for in vitro testing,
it was shown that those Pd(II) complexes produced
extremely high levels of reactive radical species and that
could be toxic to cancer cells, even more so than cisplatin.
In the presented work we have used the Pd(II), Pt(IV), and
Rh(III) complexes for the in vitro testing of cell viability
and oxidative stress on the human colorectal carcinoma
cell line HCT-116.
2. Experimental
2.1. Material and methods
The K2PdCl4, Na2PtCl6, MTT (3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide), DMSO, NBT
(nitro blue tetrazolium chloride), NED (N-1-naphthyl
ethylenediamine
dihydrochloride),
sulfanilamide,
phosphoric acid, DTNB (5,5′-dithiobis(2-nitrobenzoic
acid)), EDTA, sulfosalicylic acid, monosodium phosphate,
and disodium phosphate were obtained from Sigma
Aldrich (St. Louis, MO, USA). DMEM (Dulbecco’s
modified Eagle medium), FBS (fetal bovine serum),
PBS (phosphate-buffered saline), trypsin-EDTA, and
penicillin/streptomycin were from Thermo Fisher
Scientific (Waltham, MA, USA). The ligands TLtBu
(2,6-bis[(1,3-di-tert-butylimidazolin-2-imino)methyl]
pyridine) and LH2tBu (2,6-bis(5-tert-butyl-1H-pyrazol3-yl)pyridine) were prepared according to published
procedures (Petrovic et al., 2008; Yoshinari et al., 2012).
The complexes [(TLtBu)PdCl]+ and [Rh(LH2tBu)Cl3] were
also prepared according to prior procedures (Bogojeski
et al., 2011; Milutinović et al., unpublished data). All the
other chemicals were of the highest purity commercially
available.
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2.1.1. Synthesis and characterization of [Pt(LH2tBu)Cl3]Cl
complex
To a solution of 100 mg (0.220 mmol; 1 eq.) of Na2PtCl6
in 50 mL of water was added 71 mg (0.220 mmol; 1 eq.) of
ligand LH2tBu in 10 mL of water. The reaction mixture was
stirred overnight at 50 °C, affording a yellow precipitate.
The pH of the solution was around 5.0. The precipitate was
filtered and dried in vacuo. The product was obtained as a
yellow solid (125 mg, 84.13%).
1
H NMR (d6-DMSO): δ = 1.96 (s, 18H, CMe3), 7.37 (s,
2H; pyrazole), 8.34 (d, 2H, pyridine), 8.55 (t, 1H, pyridine)
ppm. 13C NMR (100 MHz; CDCl3): δ = 29.9 (s, CCH3), 33.0
(s, CCH3), 102.8 (s, 4C, pyrazole), 126.0 (s, 2C, pyridine),
148.3 (s, 1C, pyridine), 152.9 (s, 2C, pyrazole), 153.6 (s,
2C, pyridine), 154.2 (s, 2C, pyridine) ppm. IR (KBr, 4000–
300 cm–1): 3447 (N-H stretch); 2984, 2927, 2852 (C-H
stretch), 1634, 1574, 1483 (C=C and C=N stretch); 625
(Pt-N stretch). Anal. Calcd. for (C20H28Cl4N5Pt) C: 35.57;
H: 4.18; N: 10.37. Found: C: 36.95; H: 4.35; N: 11.06.
2.1.2. Characterization of [(TLtBu)PdCl]ClO4 complex
The complexes [(TLtBu)PdCl]+ and [Rh(LH2tBu)Cl3] were
prepared according to published procedures (Bogojeski et
al., 2011).
1
H NMR (200 MHz, D2O): δ = 7.56 (2 H, d, m-Py),
7.45 (1 H, t, p-Py), 4.57 (4 H, s, Py-CH2), and 1.68 (36 H, s,
CCH3). Anal. Calcd. for C30H52Cl2N7O4Pd: C, 47.9; H, 6.9;
N, 13.0. Found: C, 47.8; H, 6.2; N, 13.5.
2.1.3. Characterization of [Rh(LH2tBu)Cl3] complex
The complex [Rh(LH2tBu)Cl3] was prepared according to
prior procedures (Milutinović et al., unpublished data).
1
H NMR (d6-DMSO): δ = 8.19 (d, 2H, 3JHH = 7.6 Hz,
pyridine), 7.30 (t, 1H, 3JHH = 7.6 Hz, pyridine), 7.22 (s,
2H, pyrazole), 2.47 (s, 18H, CMe3) ppm. Anal. Calcd. for
(C19H25Cl3N5Rh•1.25H2O) C: 41.10; H: 4.99; N: 12.61.
Found: C: 40.95; H: 4.85; N: 12.96. IR (KBr, 4000–300 cm–
1
): 3466 (N-H stretch); 2924 (C-H stretch); 1623, 1574,
1442 (C=C and C=N stretch); 635 (Rh-N stretch).
2.1.4. Cell preparation and culturing
The human colorectal cancer cell line HCT-116 was
purchased from the American Tissue Culture Collection
(Manassas, VA, USA). The cell cultures were maintained
under controlled conditions in a humidified atmosphere
with 5% CO2 at 37 °C in 75-cm2 culture flasks. The cells
were grown in complete medium (DMEM supplemented
with 10% FBS and 100 IU/mL penicillin and 100 µg/mL
streptomycin) and seeded for experimental purposes at
70%–80% cell confluence.
2.1.5. MTT assay for cell viability
The MTT tetrazolium reaction assay is based on the
colored reduction of yellow MTT to purple formazan
in living cells (Mosmann, 1983). This color change
corresponds to the activity of mitochondria and could be
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subsequently measured at wavelengths between 550 and
600 nm. In the MTT assay 104 cells were seeded in 96-well
plates. After 24 h, the cells were treated with 100 µL of
investigated substances in a final concentration range from
0.1 to 500 µM. Cell viability was estimated 24 and 72 h after
treatment by replacing the medium containing treatment
substances with 100 µL of medium supplemented with 25
µL of MTT (concentration of 5 mg/mL PBS). After 3 h of
tetrazolium reduction reaction (in controlled conditions
of 37 °C, 5% CO2), MTT-containing medium was replaced
with 150 µL of DMSO. After 15 min, purple formazan was
well dissolved and absorbance was measured. Untreated
cells served as a negative control, while cell viability was
expressed as the ratio of measured absorbance of treated
and control cells multiplied by 100 to obtain a percentage.
A plot of % cell viability against substance concentrations
was used to calculate the concentration that showed 50%
cytotoxicity (IC50).
2.1.6. NBT assay: determination of superoxide anion
radical
The spectrophotometric assay for determining the
superoxide anion radical, O2•- , is based on measuring
the absorbance of nitroblue-formazan resulting from the
reduction of NBT in the presence of O2•·- (Auclair and
Voisin, 1985) at 550–600 nm. In this assay, 104 cells were
seeded in 96-well plates and after 24 h were treated with 100
µL of the investigated substances in a final concentration
range from 0.1 to 500 µM. The O2•·- was estimated 24 and
72 h after treatment by adding 10 µL of NBT (5 mg/mL
PBS), incubated under controlled conditions for 45 min
with subsequent measuring of absorbance. Untreated cells
served as a negative control.
2.1.7. Griess assay: determination of nitrites
Spectrophotometric detection of nitrites, which could
be considered as indicators of nitric oxide (Griess,
1879), is based on diazotation reaction of nitrites and
sulfanilamide and NED. A purple diazo product could be
spectrophotometrically detected at 520–550 nm. Similarly
to the MTT and NBT assay, 104 cells were seeded in 96well plates with subsequent treatment and after 24 and 72 h
nitrite measuring was performed. The procedure involves
using 50 µL of supernatant from 96-well plates, adding
an additional 50 µL of freshly prepared 1% sulfanilamide
(dissolved in 5% phosphoric acid) and 50 µL of freshly
prepared 0.1% NED solution. Such a prepared reaction
mixture is measured on an ELISA reader, and untreated
cells were considered as a control.
2.1.8. GSH assay: determination of reduced glutathione
The GSH assay is a spectrophotometric method based on
oxidation of the reduced form of glutathione with DTNB,
where a yellow product, 5′-thio-2-nitrobenzoic acid, is
measured at 405 nm (Baker et al., 1990). In this assay, 5
× 104 cells were seeded in 96-well plates and treated in the

same manner as in the MTT, NBT and Griess assays. First
they were disintegrated with 2.5% ice-cold sulfosalicylic
acid, and then 50 µL of supernatant was mixed with 100
µL of reaction mixture consisting of 100 mM phosphateEDTA buffer, pH 7.4, and 1 mM DTNB, followed by
measuring of absorbance on an ELISA reader. Untreated
cells were considered as a control.
2.2. Instrumentation
UV-VIS spectra were recorded on PerkinElmer Lambda
35 spectrophotometers with thermostated 1.00-cm
quartz Suprasil cells. 1H NMR measurements were
performed on a Varian Gemini 2000 NMR spectrometer
(200 MHz). Chemical analyses were performed on a
Carlo Erba elemental analyzer, model 1106. The IR
spectra were recorded on a PerkinElmer FTIR 31725.
Spectrophotometric analyses of reactive species were
conducted on a Rayto 96-well plate ELISA reader, RT2100C.
2.3. Statistics
All experiments were performed in triplicates for each
dose, and data are presented as mean ± standard error
(SE). Statistical significance was determined using the
one-way ANOVA test for multiple comparisons. P <
0.05 was considered as significant. The magnitude of
correlation between variables was determined using SPSS
17 for Windows (SPSS Inc., Chicago, IL, USA). The IC50
values were calculated from the dose curves by a computer
program (CalcuSyn).
3. Results
3.1. Complex synthesis
The Pt(IV) complex (Figure 1) was synthesized by stirring
equimolar amounts of Na2PtCl6 and the 2,6-bis(5-tertbutyl-1H-pyrazol-3-yl)pyridine ligands in water at
a pH of around 5. The obtained Pt(IV) complex was
characterized by 1H and 13C NMR spectroscopy, elemental
analysis, and IR spectroscopy.
In the 1H NMR and 13C NMR spectra of the [Pt(LH2tBu)
Cl3]+ complex signals were detected from tert-butyl groups,
pyridine ring protons, and protons of pyrazoles, which
were significantly shifted compared to the free ligand. In
the IR spectrum of the [Pt(LH2tBu)Cl3]Cl complex it can
be seen that there is a strong signal at about 3447 cm–1
corresponding to valence vibration of N-H bonds. In the
area of 2984–2852 cm–1 there are bands that originate from
symmetric valence vibration of C-H bonds. In the area of
1600–1400 cm–1 are bands derived from aromatic valence
vibration of the C=C double bond as well as the vibration
of the C=N bond. At 625 cm–1 there is a signal from the
valence vibration of the Pt-N bond.
The complexes [(TLtBu)PdCl]+ and [Rh(LH2tBu)Cl3]
were prepared according to prior procedures (Bogojeski et
al., 2011; Milutinović et al., unpublished data). The purity
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Figure 1. The structures of studied complexes along with
observation.

of the complexes was checked by NMR and elemental
analysis and good agreement was obtained.
3.2. Biological evaluation
3.2.1. Cytotoxicity of Rh(III), Pt(IV), and Pd(II)
complexes
Cytotoxicity results of the investigated complexes are
depicted in Figure 2. We found that Pd(II) exerted the
most significant cytotoxic effect with very low IC50 values

(39.1 and 1.3 µM for 24 h and 72 h after treatment). Such
a denominated cytotoxic character could be compared to
the effect of the most cytotoxic substances, e.g., cisplatin,
which under our laboratory conditions showed lower
cytotoxic effects on HCT-116 cells with IC50 values of 255
and 29 µM measured 24 and 72 h after treatment (Petrovic
et al., 2015).
3.2.2. Rh(III), Pt(IV), and Pd(II) complexes induced
oxidative stress in HCT-116 cells
The levels of superoxide anion radical and nitrites were
determined. Our results indicated a positive correlation
between radical species generation and cytotoxic cell
death: the more the increase of radicals, the greater
the cytotoxicity. The most significant cytotoxicity was
observed with Pd(II). Such cytotoxicity correlates to the
level of measured O2•- . The level of O2•- induced by Pd(II)
is the greatest in comparison to Pt(IV) and Rh(III) (Figure
3). After 24 h from treatment, the O2•- level for Pt(IV)
and Rh(III) was similar; thus, the cytotoxicity of these
two substances was also similar. On the other hand, 72 h
after treatment Pt(IV) induced much greater production
of O2•- than Rh(III), which could also be followed by
greater cytotoxicity of Pt(IV). It is interesting that Rh(III)
induced similar production of O2•- after 24 and 72 h from
treatment, and as one can observe, the cytotoxicity is quite
similar, with IC50 ranging from 208 to 226 µM.

Figure 2. The dose response curves of the effects of Rh(III), Pt(IV), and Pd(II) on HCT-116 cell growth after 24 and 72 h of
exposure. The antiproliferative effect was measured by MTT assay. All values are mean ± standard error, n = 3, *P < 0.05 as
compared with control.
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Figure 3. Effects of Rh(III), Pt(IV), and Pd(II) on HCT-116 cells, expressed as the O2•- , NO2–, and GSH concentrations
related to the number of viable cells after 24 and 72 h of exposure. All values are mean ± standard error, n = 3.

The fact that increased oxidative stress induces
cell death is largely used for production of drugs with
anticancer activity (Barrera, 2012). Besides the increasing
in O2•- it is also very important to investigate reactive
nitrogen species (RNS), which could be followed by
measuring nitrites as NO indicators. Our results show
that nitrites also increased as well as O2•-, especially for
Pd(II) and Pt(IV) (Figure 3). Rh(III) induced only slightly
increasing nitrites in the highest concentrations, Pd(II)
induced greatly increasing nitrites, and Pt(IV) induced the
most significantly increasing nitrites.
In order to understand the influence of the investigated
complexes on redox balance affected by increased
production of O2•- and nitrites, we examined the level
of GSH. Our investigation showed a significant increase
in GSH level in the following order: Pd(II) > Pt(IV) >
Rh(III). The increase for all three complexes is statistically
significant, as shown in Figure 3.
4. Discussion
As demonstrated by previous studies, complexes of
transition metals in many cases showed great cytotoxic
effect on the HCT-116 cell line (Antonarakis and Emadi,
2010; Volarevic et al., 2013). We were interested to see
whether these complexes would show similar behaviors
and what the differences between them would be. Our
complexes showed great cytotoxic effect against the

HCT-116 cell line. The cytotoxicity induced by the Pd(II)
complex was the greatest; Pt(IV) showed less effect, while
Rh(III) exerted a smaller cytotoxic effect. Similar results of
comparison of these three transition metal complexes were
shown by Schmid et al. (2007), where the Rh(III) complex
exerted little influence on human bronchial epithelial
cells, while the Pd(II) and Pt(IV) complexes showed much
greater cytotoxic effect.
Our results showed a strong relationship between cell
viability and levels of superoxide anion radical and nitrites
in the studied cell line. Many papers showed that cellular
processes and cellular compartments were affected,
leading in many cases to cell death, with the increasing of
reactive oxygen species (ROS) and RNS (Deavall, 2012).
The correlation between the level of ROS/RNS and the
cytotoxicity of the investigated substances is presented in
Figure 3. Such increasing of O2•- could be explained by the
Fenton reaction inside the cells. Namely, H2O2 present in
cells reacts with iron, yielding O2•- . Similarly, the Fenton
reaction could also be catalyzed by other transition metals,
such as palladium, platinum, or rhodium (Halliwell and
Gutteridge, 2007). Nitrites could also correlate with the
cytotoxicity of some substances, but the level of nitrites
(i.e. of NO) greatly depends on O2•- production. O2•possesses a great affinity towards NO, forming very reactive
peroxynitrites (Ferrer-Sueta and Radi, 2009), which could
induce a lowering of the content of produced NO. It is also
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quite complicated to explain the nitrite level. The content
of nitrites could depend on available nitrogen-carrying
compounds in cells that could be catabolized, especially
when we realize that the ligands of our complexes possess
many nitrogen atoms in imidazole and pyridine rings. On
the other hand, enhanced activity of iNOS protein could
also contribute to the production of NO. Our novel results
suggest that the similar Pd(II) complex actually greatly
increased nitrites by activation of iNOS protein, whose
induction was detected by immunofluorescent microscopy
assay (Živanović et al., unpublished data). Similarly to O2•production, nitrite production increased in a dose- and
time-dependent manner.
Usually the first reflection of increased oxidative
stress is the production of GSH. GSH is a tripeptide
responsible for the first defense of cells, keeping the
redox equilibrium stable. De novo synthesis of GSH in
our experiments could be explained in two ways. First,
the different chemical compositions of the investigated
substances could differentially interact with and activate
some of the enzymes in cells that are responsible for GSH
synthesis. The activation of GSH-producing enzymes
could be considered as antioxidative behavior. Having in
mind the increased O2•- and nitrites, one could conclude
both antioxidative and prooxidative behavior. Second,
substances induced increasing O2•- and nitrites, whose
higher production subsequently led to the activation of
cellular mechanisms for maintenance of redox equilibrium.
This explanation is more likely, because it was proven that
increased ROS/RNS induce activation of the thioredoxin
system, which reduces GSSG to GSH prior to maintaining
the redox equilibrium unchanged in rate (Nordberg and
Arner, 2001). This led us to conclude that the investigated
substances are rather prooxidative and thus cytotoxic to
HCT-116 cells. On the other hand, influence on GSH-

producing enzymes still remains only a possibility, and
more work is needed to elucidate this concrete model of
action of Pd(II), Pt(IV), and Rh(III).
In summary, we found that the investigated complexes
increased oxidative stress on HCT-116 cells, which caused
increased cytotoxicity. Pd(II) showed the most significant
cytotoxicity and increase of superoxide anion and nitrites,
Pt(IV) also showed considerable prooxidative and
cytotoxic effects, and Rh(III) showed little influence on the
HCT-116 cancer cell line.
Activity of the most active Pd(II) can be partly
attributed to pyridine moiety in the used ligands. Similar,
pyridine-based ligands showed antitumor activity against
various types of cancer cells. 2,2′-Bipyridine complexed
to Pd(II) showed great anticancer activity against human
leukemic K562 cells (Disalvar et al., 2011). Similarly,
terpyridine complexed to Pd(II) revealed significant
activity against MDA-MB-231 and MCF-7 breast cancer
cell lines (Ulukaya et al., 2011a) and A549, H1299, and
PC-3 nonsmall-cell lung cancer cell lines (Ulukaya et al.,
2011b) with IC50 values comparable to our results obtained
on the colorectal cancer line HCT-116 with Pd(II).
According to the literature (Ulukaya et al., 2011a),
substances with structures similar to that of the investigated
Pd(II) proved to be very effective in experiments performed
in vivo. Such substances could be seriously considered for
further, more detailed analyses. Thus, one of goals we aim
to achieve is continuing our investigations towards in vivo
testing.
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